Assessing cognitive toxicity in early phase trials - What are we missing?

Sarah E StapletonAnne-Sophie DarlingtonAnna MinchomAbhijit PalFlorence RaynaudTheresa Wiseman

Published in: Psycho-oncology (2021)

The review provides rationale for research investigating cognitive function in this context. A study exploring the cognitive function of patients on Phase I trials and the feasibility of formally assessing this within early clinical trials is currently underway at the Royal Marsden.

Keyphrases

clinical trial
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
randomized controlled trial
patient reported outcomes
oxide nanoparticles